Clinical Trial Update: A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing JTZ-951 to darbepoetin alfa in Korean patients with renal anemia on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• JTZ-951
• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Anemia of Chronic Kidney Disease | Phase 3 | Status: COMPLETED